(+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors.
(+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors.
复制标题
( /-)-cis-2-methylspiro[1,3-oxathiolane-5,3-quinuclidine] 盐酸盐,半水合物(SNI-2011,盐酸西维美林)诱导大鼠和小鼠唾液和泪液分泌:毒蕈碱乙酰胆碱的作用
DOI:
--
复制
发表时间:
1998
期刊:
影响因子:
--
通讯作者:
N. Miyata
中科院分区:
文献类型:
--
作者:
Y. Iga;H. Arisawa;N. Ogane;Y. Saito;T. Tomizuka;Y. Nakagawa;H. Masunaga;H. Yasuda;N. Miyata
We investigated effects of (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride), a rigid analogue of acetylcholine, on saliva and tear secretions in rats and mice to evaluate its therapeutical efficacy for xerostomia and xerophthalmia in patients with Sjogren's syndrome and X-ray exposure in the head and neck. Intraduodenal administrations of SNI-2011 increased saliva secretion in a dose-dependent manner at doses ranging from 3 to 30 mg/kg in normal rats and mice, two strains of autoimmune disease mice and X-irradiated saliva secretion defective rats. The salivation elicited by SNI-2011 was completely inhibited by atropine. A similar atropine-sensitive response was observed in tear secretion. In rat submandibular/sublingual gland membranes, [3H]quinuclidinyl benzilate (QNB) binding was saturable, and Scatchard plot analysis revealed a single population of binding sites with a Kd of 22 pM and a maximal binding capacity of 60 fmol/mg protein. The competitive inhibition curve of the [3H]QNB binding by SNI-2011 was obtained, and its dissociation constant value calculated from IC50 was 1-2 microM. These results suggest that SNI-2011 increases saliva and tear secretions through a direct stimulation to muscarinic receptors in salivary and lacrimal glands, and they suggest that SNI-2011 should be beneficial to patients with Sjögren's syndrome and X-ray exposure in the head and neck.
DOI:
10.1111/j.1600-0714.1988.tb01316.x
发表时间:
1988
期刊:
Journal of oral pathology
影响因子:
--
作者:
Tanaka,A;O'Sullivan,FX;Koopman,WJ;Gay,S
通讯作者:
Gay,S
影响因子:
--
作者:
HOFFMAN, RW;ALSPAUGH, MA;WALKER, SE
通讯作者:
WALKER, SE